OLIMEL N9E Emulsion for Infusion

**4.3 Contraindications** The use of OLIMEL N9E is contra-indicated in the following situations: - In premature neonates, infants and children less than 2 years of age - Hypersensitivity to egg, soya-bean, peanut proteins, or corn/corn products (see section 4.4 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_) or to any of the active substances or excipients, listed in section 6.1 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_, - Congenital abnormalities of amino acid metabolism, - Severe hyperlipidaemia or severe disorders of lipid metabolism characterised by hypertriglycaeridemia - Severe hyperglycaemia, - Pathologically-elevated plasma concentrations of sodium, potassium, magnesium, calcium and/or phosphorus.

Indication Information

**4.1 Therapeutic indications** OLIMEL N9E is indicated for parenteral nutrition for adults and children greater than 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

Basic Information

Regulatory Information

Company Information

Active Ingredients

(Compartment 3) Refined Olive Oil + Soya-bean Oil (80:20)

Detailed Information

Contraindications

Indication Information